{
    "clinical_study": {
        "@rank": "68962", 
        "arm_group": [
            {
                "arm_group_label": "Percutaneous dilatation tracheostomy: Smiths Medical", 
                "arm_group_type": "Active Comparator", 
                "description": "Type of surgical teqnique for tracheostomy: Percutaneous dilatation tracheostomy. The set for the tracheostomy is bought from Smiths Medical TM."
            }, 
            {
                "arm_group_label": "Open surgery tracheostomy", 
                "arm_group_type": "Active Comparator", 
                "description": "Type of surgical teqnique for tracheostomy: Open surgical tracheostomy"
            }
        ], 
        "brief_summary": {
            "textblock": "The main purpose of this study is to examine if there are differences in postoperative\n      inflammation following percutaneous dilatation tracheostomy versus surgical tracheostomy in\n      intensive care unit patients."
        }, 
        "brief_title": "Postoperative Inflammation and Recovery After Tracheostomy", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Tracheostomy Complication", 
            "Inflammation", 
            "Post-operative Complications"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Postoperative Complications"
            ]
        }, 
        "detailed_description": {
            "textblock": "Are there differences between the two arms in plasma concentrations of inflammatory\n      mediators (TNF-alfa, interleukin 1, 6, 10) at 24 hrs following the start of the surgical\n      procedure? Are there differences between the two arms in the incidence of postoperative\n      complications (i.e. bleeding, incidence of stomal infections, tracheal tube dislocation,\n      airway compromisation), postoperative pulmonary infection (during the stay in the ICU) and\n      pulmonary function (FEV1, dynamic complicance, oxygen demand, time to weaning off the\n      ventilator: all measured daily during the ICU-stay), postoperative mobilization (time to\n      mobilization to sitting, standing and walking, respectively)?"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria: Patients in whom a tracheostomy is indicated (i.e. anticipated need of\n        mechanical ventilation for >7 days or anticipated risk for complicated extubation, e.g.\n        anatomical signs of a compromised airway, reduced level of consciousness. Adults over 18\n        years. Participants who are suitable for both surgery techniques.\n\n        Exclusion Criteria:\n\n        Children under 18 years, pregnancy and participants with anatomical defects that exclude\n        them from percutaneous dilatation tracheostomy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02096640", 
            "org_study_id": "2013/1136-31/2", 
            "secondary_id": "2013/1136-31/2LTS"
        }, 
        "intervention": {
            "arm_group_label": [
                "Percutaneous dilatation tracheostomy: Smiths Medical", 
                "Open surgery tracheostomy"
            ], 
            "intervention_name": "Type of surgical teqnique for tracheostomy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 23, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Eskilstuna", 
                    "country": "Sweden", 
                    "state": "S\u00f6rmland", 
                    "zip": "631 88"
                }, 
                "name": "Intensivv\u00e5rdsavdelningen p\u00e5 M\u00e4larsjukhuset"
            }, 
            "investigator": [
                {
                    "last_name": "Ulrika H Skoog", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Markus Castegren, MD, PhD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Controlled Trial on the Effect of Percutaneous Dilatation Tracheostomy Compared to Open Surgical Tracheostomy on Postoperative Inflammation, Pulmonary Function, Peri- and Postoperative Complications and Physical Mobilization.", 
        "other_outcome": {
            "description": "Notes 7 Days after tracheostomy on the time to mobilization to sitting, standing and walking, respectively.", 
            "measure": "Physical function", 
            "safety_issue": "No", 
            "time_frame": "One week after tracheostomy"
        }, 
        "overall_contact": {
            "email": "ulrika.skoog@dll.se", 
            "last_name": "Ulrika H Skoog, PTh", 
            "phone": "016-104570"
        }, 
        "overall_contact_backup": {
            "email": "markus.castegren@dll.se", 
            "last_name": "Markus Castegren, MD, PhD", 
            "phone": "016-105737"
        }, 
        "overall_official": {
            "affiliation": "Centre for Clinical Research, Uppsala University", 
            "last_name": "Markus Castegren, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Plasma samples will be taken preoperative and 24 hours after the start of tracheostomy. The levels of TNF-alpha, IL-6 and IL-10 will be measured.", 
            "measure": "Change in inflammation markers in plasma", 
            "safety_issue": "No", 
            "time_frame": "Preoperative and 24 hours after the start of surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02096640"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sormland County Council, Sweden", 
            "investigator_full_name": "Markus Castegren", 
            "investigator_title": "Med. dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "All postoperative complications will be noted daily during the ICU-stay, i.e. bleeding, incidence of stomal infections, tracheal tube dislocation, airway compromisation.", 
            "measure": "Postoperative complications", 
            "safety_issue": "Yes", 
            "time_frame": "Until discharge from the ICU"
        }, 
        "source": "Sormland County Council, Sweden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sormland County Council, Sweden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}